SCHEMBL6558153

SCHEMBL6558153

CC(C)(NC(=O)OCc1ccccc1)c1ccc(C(=O)Nc2ccncc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.62
NAMPT P43490 4/20 0.53
JAK2 O60674 1/20 0.52
TYK2 P29597 1/20 0.52
STAT3 P40763 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
SCD O00767 1/20 0.51
DNMT1 P26358 1/20 0.49
DNMT3A Q9Y6K1 1/20 0.49
HTT P42858 1/20 0.49
KDM4E B2RXH2 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KDM1A O60341 1/20 0.48
RCOR1 Q9UKL0 1/20 0.48
ROCK2 O75116 1/20 0.48
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557650 0.82 SMN1; SMN2 (0.50) SMN1; SMN2LMNAMEN1NPC1RAB9A
SCHEMBL996878 0.81 NAMPT (0.78) POLBNAMPTJAK2TYK2STAT3
SCHEMBL6558932 0.80 SMN1; SMN2 (0.48) SMN1; SMN2KDM1ARCOR1LMNAMEN1
SCHEMBL2790938 0.80 POLB (0.64) POLBNAMPTJAK2TYK2STAT3
SCHEMBL14349181 0.79 SMN1; SMN2 (0.52) POLBSMN1; SMN2L3MBTL1LMNAMEN1
SCHEMBL6560029 0.79 POLB (0.60) POLBNAMPTJAK2TYK2STAT3
SCHEMBL6560020 0.79 POLB (0.60) POLBNAMPTJAK2TYK2STAT3
SCHEMBL6560027 0.79 POLB (0.63) POLBNAMPTJAK2TYK2STAT3
SCHEMBL13679756 0.78 POLB (1.00) POLBNAMPTSMN1; SMN2KDM1ARCOR1
SCHEMBL6558160 0.78 POLB (0.58) POLBNAMPTJAK2TYK2STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391454-A1 Substituted benzamide compounds with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2004-02-25 EP disclosed
EP-1195372-A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2002-04-10 EP disclosed
US-6156766-A Benzamide compounds and pharmaceutical use thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-12-05 US disclosed
US-5958944-A TREATMENT OF CIRCULATORY DISEASES IN CORONARY, CEREBRAL, RENAL AND PERIPHERAL ARTERIES, AS A THERAPEUTIC AGENT FOR HYPERTENSION, ANGINA PECTORIS, AND RENAL AND PERIPHERAL CIRCULATION DISORDER, ANTIASTHMATIC AGENT YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1999-09-28 US disclosed
EP-0757038-A1 BENZAMIDE COMPOUND AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-02-05 EP disclosed